Navigation Links
MicroRNAs present exciting opportunities for cancer therapy and diagnosis
Date:12/19/2012

Amsterdam, NL, December 19, 2012 As many as 50 percent of all human protein-coding genes are regulated by microRNA (miRNA) molecules. While some miRNAs impact onset and progression of cancer, others can actually suppress the development of malignant tumors and are useful in cancer therapy. They can also serve as potential biomarkers for early cancer detection. In a new issue of Cancer Biomarkers, investigators report on non-coding miRNAs as appealing biomarkers for malignancy.

"MiRNA-based therapies are attractive partly due to the fact that these molecules can target multiple genes in different signaling pathways simultaneously," says guest editor Pier Jr Morin, PhD, MBA, Assistant Professor of Biochemistry, Department of Chemistry and Biochemistry, Universit de Moncton, New Brunswick, Canada. "In addition to their therapeutic potential, miRNAs are released into the circulation, and measurement of such species in plasma and serum samples highlights the possibility of leveraging these molecules as potential biomarkers for early cancer detection, prognostic assessment, and evaluation of therapeutic response in cancer patients."

Six articles follow Dr. Morin's editorial, each discussing the diagnostic and therapeutic potential of miRNAs across a variety of cancer malignancies.

In "The Value of MiRNA in Diagnosing Thyroid Cancer: A Systematic Review," L. Lodewijk and colleagues address the diagnostic potential of miRNAs in thyroid cancer.

Niamh M. Hogan, Myles R. Joyce, and Michael J. Kerin discuss the need to identify new biomarkers to detect colorectal cancer in its early stages. It has been shown that five-year patient survival increases from 10 percent at stage IV detection to more than 90 percent at an early stage, an important finding for this fourth most common cause of death from cancer. Investigators outline the advantages of current methods of colorectal cancer detection, identify challenges, and assess miRNA
'/>"/>

Contact: Daphne Watrin
d.watrin@iospress.nl
31-206-883-355
IOS Press
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. MicroRNAs in plants: Regulation of the regulator
2. Cell therapy using patients own bone marrow may present option for heart disease
3. Report presents designs for study of cancer risks near US nuclear facilities
4. Entomology 2012 to present 105 insect symposia in November
5. NYU School of Medicine presents 2012 Dart/NYU Biotechnology Achievement Awards
6. The Brain Prize 2012 is presented May 9th
7. Validity CTO to Present Natural ID Solutions for Improving Mobile Risk Management and User Experience at NFC Solutions Summit 2012
8. John Theurer Cancer Center presents significant blood cancer research at 2012 ASCO Annual Meeting
9. Amarantus BioSciences to Present at the National Investment Banking Associations (NIBA)122nd Conference in New York City
10. Coral reef experts to present latest coral reef science during July symposium
11. FirstMark Exhibiting and Presenting at the San Diego Academy of Family Physicians 55th Annual Postgraduate Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/2/2015)... 2, 2015 In the ... far outperforms the strongest competitors, showing outstanding performance ... the system is capable of a throughput of ... up to be ten times faster than most ... performance.      (Photo: http://photos.prnewswire.com/prnh/20150402/738673-a ...
(Date:4/1/2015)... Medisafe ™, the leading global medication management platform with ... Android smartphones and tablets, announces today that ... allow patients to track and correlate their adherence directly ... be able to visualize in real-time how taking medication ... glucose levels and blood pressure. "Patients need ...
(Date:3/24/2015)... DUBLIN , Mar. 24, 2015 Research and ... addition of the "Global Iris Recognition Market 2015-2019" ... forecast the Global Iris Recognition market to grow at ... This report covers the present scenario and ... for the period 2015-2019. To calculate the market size, ...
Breaking Biology News(10 mins):DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2
... took the wraps off a new,line of sleek, powerful, ... Weighing just over 3 pounds, the VAIO Z model ... LCD,technology for scratch-resistant durability and 100 percent color,saturation., ... display,providing a 40 percent wider workspace than a standard ...
... The Ecological Society of America (ESA) will present societal ... ESA meeting in Milwaukee, Wisconsin on Monday, August 4, ... , Michael Rosenzweig of the University of Arizona is ... to a senior ecologist in recognition of an outstanding ...
... Society for Microbiology (ASM) Procter & Gamble Award ... to Edward F. DeLong, Professor, Massachusetts Institute of ... and development in applied and environmental microbiology. ... in the field of marine microbiology. His work ...
Cached Biology News:New Sony PC Delivers High Performance in Ultra-Portable Package 2New Sony PC Delivers High Performance in Ultra-Portable Package 3Ecological Society of America announces 2008 award recipients 2Ecological Society of America announces 2008 award recipients 3Ecological Society of America announces 2008 award recipients 4American Society for Microbiology honors Edward F. DeLong 2
(Date:5/4/2015)... , May 4, 2015   Sentrian ™, ... hospitalizations, has teamed with the Scripps Translational Science ... technology on 1,000 patients with chronic obstructive pulmonary disease ... Americans and is the nation,s third leading cause of ... CareMore Health System , a wholly owned subsidiary ...
(Date:5/1/2015)... /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ), an ... has priced an underwritten registered offering of 3,900,000 shares ... per share, and granted the underwriters in the offering ... 585,000 shares of its common stock. The gross proceeds ... expected to close on May 6, 2015, subject to ...
(Date:5/1/2015)... -- Investor-Edge has initiated coverage on ... GENE ), Agilent Technologies Inc. (NYSE: A ... ), Sequenom Inc. (NASDAQ: SQNM ), and ... report on Genetic Technologies can be accessed at ... the NASDAQ Composite ended at 4,941.42, down 1.64%, ...
(Date:4/30/2015)... South Carolina (PRWEB) May 01, 2015 ... system services, is extremely proud to announce that for ... been named as a winner of a Queen’s Award ... success for the design and manufacture of a unique ... is the revolutionary alternative to traditional steam flow measurement. ...
Breaking Biology Technology:CareMore, Scripps Translational Science Institute, and Sentrian Launch Landmark Study of Remote Patient Monitoring for COPD Population 2CareMore, Scripps Translational Science Institute, and Sentrian Launch Landmark Study of Remote Patient Monitoring for COPD Population 3CareMore, Scripps Translational Science Institute, and Sentrian Launch Landmark Study of Remote Patient Monitoring for COPD Population 4CareMore, Scripps Translational Science Institute, and Sentrian Launch Landmark Study of Remote Patient Monitoring for COPD Population 5BioAmber Inc. Announces Pricing Of $35.1 Million Registered Offering 2BioAmber Inc. Announces Pricing Of $35.1 Million Registered Offering 3Life Sciences Tools and Services Stocks on our Radar -- Genetic Technologies, Agilent Technologies, Thermo Fisher Scientific, Sequenom, and PerkinElmer 2Life Sciences Tools and Services Stocks on our Radar -- Genetic Technologies, Agilent Technologies, Thermo Fisher Scientific, Sequenom, and PerkinElmer 3Life Sciences Tools and Services Stocks on our Radar -- Genetic Technologies, Agilent Technologies, Thermo Fisher Scientific, Sequenom, and PerkinElmer 4Life Sciences Tools and Services Stocks on our Radar -- Genetic Technologies, Agilent Technologies, Thermo Fisher Scientific, Sequenom, and PerkinElmer 5Spirax Sarco Receives a Queen’s Award for Innovation 2Spirax Sarco Receives a Queen’s Award for Innovation 3
... England, November 26 Sosei,Group Corporation ("Sosei"; TSE Mothers ... out-licensed its IP and Know How,relating to the RS(+) ... based pharma company, for the treatment and prophylaxis of,malaria. ... a highly efficacious anti-malarial drug that is approved in,its ...
... 25 Beckman Coulter, Inc. (NYSE: BEC ), ... automate, and innovate complex biomedical testing, announced today that Paul ... will present at the following conferences: , ... , , ...
... COLUMBUS, Ohio, Nov. 25 CAS REGISTRY, the world,s ... million organic and inorganic substances. CAS Registry Number(R),1073662-18-6 recently ... (Photo: http://www.newscom.com/cgi-bin/prnh/20081125/CLTU095 ) ... http://www.newscom.com/cgi-bin/prnh/20070817/CLF008LOGO ) , ...
Cached Biology Technology:Sosei Announces the Out-licensing of RS(+) Mefloquine to Treague Ltd for the Treatment and Prophylaxis of Malaria 2Beckman Coulter to Present at Upcoming Healthcare Conferences 2CAS Registers 40 Millionth Substance in CAS REGISTRY(SM) 2
... custom siRNA service provides the premium quality ... research. Custom siRNAs can be readily ordered ... target sequence, or by providing the sense ... Ambion's Silencer Validated and ...
... the premium quality siRNAs you need for ... be readily ordered online by providing either ... providing the sense and antisense siRNA sequences. ... Validated and Silencer Pre-designed siRNAs, ...
dithiothreitol, sulfhydryl reducing agent, C4H10O2S2; MW: 154.24, 97% pure (minimum), CAS No: 27565-41-9, store at -20 C ...
... NAP-10 Columns, 50. For rapid and ... 10-mers) in less than 15 minutes by ... in distilled water containing 0.15% Kathon CG/ICP ... volume: 0.5 ml (NAP-5), 1 ml ...
Biology Products: